These results add to the growing body of evidence indicating a single dose of ABRYSVO provides strong immune protection against outcomes caused by RSV
Decision on EU marketing authorisation for this population expected by September 2024
Integrated Disease Surveillance Programme (IDSP) strengthened to improve disease surveillance and rapid data reporting
The agreement has an initial term until March 31, 2029 and no further details on the financial terms of the deal are being disclosed
India boasts the largest livestock population, with 536 million livestock and 851 million poultry
Offering testing, treatment and support to help stop the spread of HIV and other infectious diseases
Innovative technology represents a breakthrough scientific achievement for highly contagious respiratory disease
Over 13 million US adults aged 50-59 years have a medical condition that increases their risk of severe RSV outcomes
The Gavi Board today approved the Vaccine Alliance's strategy for the five-year period running from 2026 to 2030
mRESVIA is Moderna's second approved product and the only RSV vaccine available in single-dose pre-filled syringes
Subscribe To Our Newsletter & Stay Updated
